THE ECONOMIC VALUE OF PREVENTING RESPIRATORY AND CARDIOVASCULAR HOSPITALIZATIONS
- 1 January 2006
- journal article
- Published by Wiley in Contemporary Economic Policy
- Vol. 24 (1) , 127-143
Abstract
This article provides estimates of the economic benefits of reducing respiratory and cardiovascular hospitalizations based on cost of illness and willingness to pay. The willingness‐to‐pay estimates indicate that individuals value prevention of a five‐day hospitalization event at an average of approximately $2,400. Average total costs of illness per hospitalization are $22,000–39,000. A comprehensive cost‐of‐illness estimate that includes value of time losses for the hospitalization and at‐home recovery periods provides a close approximation of total costs borne by third parties plus individual willingness to pay. Both exceed previous cost‐of‐illness estimates by about 10–25%. (JEL D61, I18, Q25)Keywords
This publication has 6 references indexed in Scilit:
- Willingness to pay for improved respiratory and cardiovascular health: a multiple-format, stated-preference approachHealth Economics, 2000
- The Costs of Cardiorespiratory Disease Episodes in a Study of Emergency Department UseCanadian Journal of Public Health, 2000
- Beyond Administrative Data: Characterizing Cardiorespiratory Disease Episodes Among Patients Visiting the Emergency DepartmentCanadian Journal of Public Health, 2000
- Cost-of-Illness and Willingness-to-Pay Estimates of the Benefits of Improved Air Quality: Evidence from TaiwanLand Economics, 2000
- Valuing the benefits of health and safety regulationJournal of Urban Economics, 1987
- TRAVEL TIME AND THE PRICE OF LEISUREEconomic Inquiry, 1966